Our Belief

Over the years, the biological market has expanded and will continue to grow. Most novel drugs are still not affordable for the general population worldwide. Every multi-million dollar biologic is a result of the high cost of the drug, as opposed to the population it benefits. 

We at BRL work tirelessly to ensure that essential, life-saving biologics can become more accessible and affordable for all.

Pipetting Samples and Test Tube
Molecules
BRL_Bhami_Shenoy.png

Dr. Bhami Shenoy, PhD

Co-Founder

&

Chief Science Office

BRL_Surya_Pai.png

Dr. Surya Pai, BDS

Co-founder 

&

CEO

BRL_Viren_Sarin.png

Dr. Viren Sarin, PhD

Scientific Advisor

Retd. Distinguished Fellow, Eli Lilly